Myopia Control Combined PBM With Myopic Defocus Lens in Children
Condition(s) studied
Investigational drug(s) / intervention(s)
PBM: PBM, is a low intensity red light at wavelength of 650nm; Peripheral defocus spectacels is a peripheral design glasseses for correct myopia and control myopia
Peripheral defocus spectacles: plus power design of many peripheral small lenses to achieve myopic defocus of the retina in the peripheral retina
Single vision spectacles: Distance vision correction with the single vision spectacles for the myopia correction methods (glasseses for myopia correction)
Study summary
To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.
Eligibility
Primary outcome measure(s)
- axial length (mm) — 6 month
Axial length changes at follow-up of 6 month from baseline will be measured by IOLmaster 500 at the same site by the same examiner with the mean values of 5 times measurements at either time. Changes in axial length (mm) without cycloplegia are to be measured by IOLmaster(Carl Zeiss). Five measurements will be taken and then averaged. - SE (Diopter, D) — 6 month
changes of cycloplegic spherical equivalent from baseline will be measured under cycloplegic refraction by autorefractor. Five measured by the same autorefractor are to be obtained for each eye.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| the first people's hospital of Xuzhou | Xuzhou | Jiangsu | Recruiting |
More Beijing Airdoc Technology Co., Ltd. trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05756959 on ClinicalTrials.gov ↗ ← All trials in China